ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Pluri Inc

Pluri Inc (PLUR)

6.0199
-0.1501
(-2.43%)
Closed May 25 4:00PM
6.0199
0.00
(0.00%)
After Hours: 4:05PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
6.0199
Bid
4.51
Ask
6.90
Volume
2,263
5.4695 Day's Range 6.325
3.4488 52 Week Range 8.56
Market Cap
Previous Close
6.17
Open
6.14
Last Trade
2
@
5.62
Last Trade Time
Financial Volume
$ 13,272
VWAP
5.8646
Average Volume (3m)
71,885
Shares Outstanding
41,480,172
Dividend Yield
-
PE Ratio
-8.82
Earnings Per Share (EPS)
-0.68
Revenue
287k
Net Profit
-28.32M

About Pluri Inc

Pluristem Therapeutics Inc is registered with the U.S. Security and Exchange Commission and incorporated in the state of Nevada. Pluristem Therapeutics Inc is primarely in the business of biological products (no diagnostic substances). For financial reporting, their fiscal year ends on June 30th. Th... Pluristem Therapeutics Inc is registered with the U.S. Security and Exchange Commission and incorporated in the state of Nevada. Pluristem Therapeutics Inc is primarely in the business of biological products (no diagnostic substances). For financial reporting, their fiscal year ends on June 30th. This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Pluristem Therapeutics Inc. Pluristem Therapeutics Inc is a US-based company which acts as a developer of placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory and hematologic conditions. The lead indications are critical limb ischemia, recovery after surgery for femoral neck fracture, and acute radiation syndrome. The company operations are focused on the research, development, clinical trials and manufacturing of cell therapeutics and related technologies. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Headquarters
Haifa, North, Isr
Founded
1970
Pluri Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker PLUR. The last closing price for Pluri was $6.17. Over the last year, Pluri shares have traded in a share price range of $ 3.4488 to $ 8.56.

Pluri currently has 41,480,172 shares outstanding. The market capitalization of Pluri is $249.71 million. Pluri has a price to earnings ratio (PE ratio) of -8.82.

PLUR Latest News

Novel Medical Food Solution for the Elderly: Pluri & Wilk Collaborate to Develop Human Breast Milk-Derived Food Production on a Commercial Scale

New production process will be developed based on Pluri’s proprietary 3D cell expansion technologyHuman breast milk oligosaccharides are known to shape the gut microbiota and thus provide health...

Unleashing the Power of MAIT Cells: Pluri Launches Novel Immunotherapy Platform for Solid Tumor Cancer Treatment

Placental Mucosal Associated Invariant T (MAIT) cells are unique unconventional immune T cells which are particularly suitable for the treatment of solid tumors, a significant unmet medical...

Breakthrough in Immune Cell Expansion: Pluri Granted U.S Patent for New Method

Pluri’s patent enables mass-scale production of immune cell therapiesNew patented technology is applicable for the expansion of a variety of immune cellsTechnology sets stage for potential immune...

Pluri’s Business Verticals Gain Traction in Global Markets; Leadership to Participate and Present in Upcoming Conferences

HAIFA, Israel, March 28, 2024 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq:PLUR) (TASE:PLUR) ("Pluri" or "the Company"), a leading biotechnology company that transforms cells into solutions that...

Pluri Inc. Announces 1-for-8 Reverse Share Split

HAIFA, Israel, March 27, 2024 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR) ("Pluri" or the “Company"), a leading biotechnology company that transforms cells into solutions, today...

Pluri’s Sustainable Cell-Based Coffee Addresses Critical Challenges Revealed in International Coffee Organization Market Report

International Coffee Organization (ICO) Market Report published on March 7, 2024 highlights alarming price instability challenging the coffee industryAccording to the report, adverse weather...

Engage with Pluri's Talent: Exciting Conference Appearances Ahead

HAIFA, Israel, March 19, 2024 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq:PLUR) (TASE:PLUR) ("Pluri" or "the Company"), a leading biotechnology company that transforms cells into solutions that...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.4601-7.100308641986.486.485.469548736.11316327CS
41.199924.89419087144.826.554.73108005.78205017CS
12-0.5401-8.233231707326.568.484.5718856.81207098CS
261.139923.35860655744.888.483.7728867685.81451996CS
52-0.3161-4.98895202026.3368.563.4488754015.71802298CS
156-1.9801-24.75125811.57843.4488710606.47100389CS
260-1.9801-24.75125811.57843.4488710606.47100389CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
LUCYInnovative Eyewear Inc
$ 0.983
(428.49%)
944.4M
AKANAkanda Corporation
$ 4.07
(70.29%)
39.11M
TKLFYoshitsu Company Ltd
$ 0.3496
(53.33%)
84.5M
ONMDOneMedNet Corporation
$ 2.251
(53.13%)
136.04M
MRUSMerus NV
$ 59.92
(35.97%)
6.91M
VSTMVerastem Inc
$ 4.0901
(-66.42%)
19.68M
TOIIWOncology Institute Inc
$ 0.0443
(-55.61%)
280.55k
SNSESensei Biotherapeutics Inc
$ 0.7912
(-45.43%)
1.41M
GNLXGenelux Corporation
$ 2.61
(-43.26%)
3.32M
AUVIApplied UV Inc
$ 0.32
(-33.33%)
5.18M
LUCYInnovative Eyewear Inc
$ 0.983
(428.49%)
944.4M
GWAVGreenwave Technology Solutions Inc
$ 0.0843
(-4.85%)
428.98M
NCPLNetcapital Inc
$ 0.20
(14.42%)
191.35M
HLTHCue Health Inc
$ 0.0931
(-1.27%)
160.21M
ONMDOneMedNet Corporation
$ 2.251
(53.13%)
136.04M

PLUR Discussion

View Posts
Scott999 Scott999 2 days ago
Always a ton of pootential with the clown crew. Would have tripled their revenue by just selling their clown noses.
👍️0
FDApproved FDApproved 2 days ago
Huge Market Potential !!!

https://www.proteinproductiontechnology.com/post/pluri-and-wilk-collaborate-to-develop-human-breast-milk-derived-food-production-on-a-commercial-scale
👍️ 1
Scott999 Scott999 2 days ago
All the fluff in the world is doing jack squat for this pig. They’re getting desperate and you’ll see a raise very soon I’m sure. Like clockwork.
👍️0
Scott999 Scott999 2 days ago
All the fluff in the world is doing jack squat for this pig. They’re getting desperate and you’ll see a raise very soon I’m sure. Like clockwork.
👍️0
Scott999 Scott999 4 days ago
Cmon the whole world is going to feed their babies manufactured milk. They won’t try a piece of meat but they’re gonna slap that bottle of grown milk into their kids chops. Once approval happens in 2058, it’ll be smooth sailing for Kaki and his clown crew.
👍️0
sekander sekander 4 days ago
You're wasting your time with these scam "updates". This well dried up for the clowns a long time ago.
Only newbie suckers who don't read message boards are available to be fleeced.
👍️0
FDApproved FDApproved 5 days ago
WOW !!! Novel Medical Food Solution for the Elderly: Pluri & Wilk Collaborate to Develop Human Breast Milk-Derived Food Production on a Commercial Scale

https://pluri-biotech.com/releases/novel-medical-food-solution-for-the-elderly-pluri-wilk-collaborate-to-develop-human-breast-milk-derived-food-production-on-a-commercial-scale/
👍️ 1
FDApproved FDApproved 6 days ago
Wow....This Is A Game-Changer !!!

https://pluri-biotech.com/mait-pluri-health/
👍️ 1
Scott999 Scott999 1 week ago
Yes they’re in the discovery phase of their solid tumor investigations. Woohoo!!! Didn’t they mention this a decade ago? Only ten short years to get to the discover phase of this earth shattering news they announced. In a mere 2 centuries, they should have completed their phase 1, them pivot back to ARS or preeclampsia.

What’s even more impressive is how Kaki is using the exact same verbiage the og clown Zami used for 15 years. A few it’s and ands changed around, but pretty much identical speeches. Hey when you got a good legal scam going, why change a thing.
👍️ 1
FDApproved FDApproved 1 week ago
WOW !!!

👍️ 2
Scott999 Scott999 2 weeks ago
Well how many times have we seen this. Any day we should get a raise at a 10 to 20% discount. It’s imminent imo
👍️0
sekander sekander 2 weeks ago
All aboard the Titanic!!
What a joke of a stock. Moves up 10% on 12,000 shares traded.
Gimme a break. Wake me when we get back to a dollar.
👍️0
FDApproved FDApproved 2 weeks ago
Pluri CDMO: Chief Commercial Officer Andy Lewin Interview

https://www.phacilitate.com/learning-from-experience-navigating-cell-gene-therapy-development-challenges-with-productive-cdmo-partnerships/
👍️ 2
FDApproved FDApproved 2 weeks ago
All Aboard !!!

https://kenes-exhibitions.com/biomed/?gad_source=1&gclid=Cj0KCQjwhtWvBhD9ARIsAOP0Gohffys13bxoPAqgDNYKFt4scQqwrv2c1YT4zfGxHSRe8M_euOMMy9YaAinLEALw_wcB
👍️ 2
FDApproved FDApproved 3 weeks ago
Pluri Biotech May Investor Presentation Is Out !!!

https://pluri-biotech.com/presentation/
👍️ 2
Scott999 Scott999 3 weeks ago
And in 10 years they should have their phase 1 results. Good thing companies like Merck below, are just starting phase 3 trials on solid tumors. Pluristem with all their ex Elbit Vision System employees should be able to leapfrog Merck’s trials in a couple decades.

https://www.merck.com/news/merck-announces-phase-3-trial-initiations-for-four-investigational-candidates-from-its-promising-hematology-and-oncology-pipeline/

Or all these other trials going on. But ya Pluristem and Kaki the accountant clown got this.

https://molecular-cancer.biomedcentral.com/articles/10.1186/s12943-023-01723-z
👍️ 2
FDApproved FDApproved 3 weeks ago
Incredible, Pluri Has Developed A Fully Allogeneic CD8 Positive T-Cell That Is A Off-The-Shelf Solid Tumor Treatment And Grown On An Industrial Scale !!!

ONLY ONE IN THE WORLD FOLKS-Pay Attention To What's Coming !!!

MAIT cells are a type of T cell, which is responsible for attacking harmful pathogens in the body like cancer cells. MAIT cells, however, are not well understood compared to other immune cells. Aug 17, 2023
👍️ 2
Scott999 Scott999 3 weeks ago
They peddled this years ago. They’re just rehashing headlines to dupe a new slew of investors to keep the paycheques coming for the 150 plus employees who have billed investors out of soon to be half a billion dollars with zero to show for it over 20 years and Zzatty boys going to have a freak out over this run on sentence while screaming we got Zzientists after going through his second rs making the tens of thousands of shares he bought over $20 that are now at a price of $160 after the last rs. Hey didn’t he call ME an idiot many times? LMAO x200k

Those original 200k shares he bragged about went down to 20k shares after the first 1 for 10. Now after the last 1 for 8 its down to 2500 shares. Oh the humanity. Not to worry though. To imagine going from 200,000 shares to 2500 shares must have been devastating. But he still loves this management team no doubt. And don’t forget, he’s seen splits before that have worked out.

Can only laugh at this point. But I’m sure he’s going to have a massive Chubb after learning about a new scientific board. Kinda reminds me of the preeclampsia board they put together for their pre clinical studies that went nowhere like everything else they’ve touched.

And you’ll be happy to know I’ve come up with Pluristem’s new motto.

Pluristem…The Perpetual Startup.
👍️ 1
FDApproved FDApproved 3 weeks ago
WOW !!! WOW !!! WOW !!! WOW !!! WOW !!!

https://pluri-biotech.com/releases/unleashing-the-power-of-mait-cells-pluri-launches-novel-immunotherapy-platform-for-solid-tumor-cancer-treatment/
👍️ 2
FDApproved FDApproved 3 weeks ago
PLURI BIOTECH SHAREHOLDER MEETING IS JUNE 25TH !!!

https://www.sec.gov/Archives/edgar/data/1158780/000121390024038145/ea0204843-def14a_pluri.htm
👍️ 2
Monksdream Monksdream 4 weeks ago
PLUR under $10
👍️0
FDApproved FDApproved 4 weeks ago
Correction: The TASE Is Closed Sunday & Monday
👍️0
FDApproved FDApproved 1 month ago
Listen To What Yaky Says At The 3 Minute and 15 Second Point !!!

WOW !!! Ever After Foods Is Going BIG TIME !!!

👍️ 2
FDApproved FDApproved 1 month ago
FYI: TASE Is Closed On Monday & Tuesday.
👍️0
midastouch017 midastouch017 1 month ago
Too bad the entire market does
not appreciate PLURI's potential.
I thought i was the only one who
does not!
4.8420-0.2080 (-4.1188%)
As of 10:29AM EDT. Market open.
👍️0
sekander sekander 1 month ago
Wow. If things keep going like they're going, we're gonna need another
reverse split by the end of the year.
👍️0
FDApproved FDApproved 1 month ago
WOW !!! The Cow Has Left The Barn And Jumped Into Pluri's 3D Bioreactor !!!

In This Video Today, Yaky Says They, Being (Ever After Foods) Have Partnered With One Of The Largest Meat Producers In The World !!! That Puts Cargill & JBS At The Top Of the List !!! WOW !!!

👍️ 2
sekander sekander 1 month ago
I am very well able to grasp the thinly veiled scam that is this company.
Potential? HAH! After 10 years, one has to wonder if there is any real
intent to do anything. Projects come and projects go but nothing is ever
seen to conclusion. Just a lot of pie in the sky rhapsodizing meant to draw
in the next batch of suckers. If they didn't do reverse splits, you'd need a
microscope to find the share price.
👍️ 1
FDApproved FDApproved 1 month ago
You Never Will Be Able To Grasp/Understand Pluri's Technology & Potential !!!

That's Okay, As We Love Sideline Sally's With Their Beautiful Pom Poms !!!
👍️ 1
sekander sekander 1 month ago
New board, same garbage stock.
The endless death spiral continues. You can try changing your name but a leopard can't change his spots.
This leopard/turkey is headed straight for the dumpster. Still not one positive indicator in 10 years.
👍️0
TrendTrade2016 TrendTrade2016 1 month ago
PLUR...POST SPLITY BOOM IN PLACE
👍️ 2
midastouch017 midastouch017 2 months ago
Very warm market reaction towards the news!
👍️0
FDApproved FDApproved 2 months ago
Breakthrough in Immune Cell Expansion: Pluri Granted U.S Patent for New Method

https://markets.businessinsider.com/news/stocks/breakthrough-in-immune-cell-expansion-pluri-granted-u-s-patent-for-new-method-1033229167
👍️ 2
midastouch017 midastouch017 2 months ago
And with it you also have no business!

5.29-0.13 (-2.40%)
As of 01:25PM EDT. Market open.
Volume 571,492
Avg. Volume 17,671

When will you learn, a patent is only worthwhile
if and when someone pays you to make use of it.
👍️0
midastouch017 midastouch017 2 months ago
After 3 consecutive r/s i wonder how much
wisdom i can achieve from a dry prune that
you are!
👍️ 1
FDApproved FDApproved 2 months ago
And Without It You Have No Business !!! You Have Much To Learn Grasshopper !!!
👍️ 2
midastouch017 midastouch017 2 months ago
A patent is only a patent.
I wager besides the immediate frenzy,
stock will end at no more than +5% from
closing day Friday!
👍️0
FDApproved FDApproved 2 months ago
Pluri Biotech Is In The Driver's Seat Now !!!

I Hear Big Pharma Knocking At The Door !!!

https://www.globenewswire.com/news-release/2024/04/08/2859054/11974/en/Breakthrough-in-Immune-Cell-Expansion-Pluri-Granted-U-S-Patent-for-New-Method.html
👍️ 2
FDApproved FDApproved 2 months ago
WOW !!!

https://www.marketscreener.com/quote/stock/PLURI-INC-62637874/news/Breakthrough-in-Immune-Cell-Expansion-Pluri-Granted-U-S-Patent-for-New-Method-46385901/
👍️ 2
FDApproved FDApproved 2 months ago
Pluri™ Receives First-Ever Patent Approval for 3D Bioreactor Technology in Plant Cell Cultivation

https://pluri-biotech.com/wp-content/uploads/2024/03/1710196121_1710148623_Pluri_PR_re._Plant_Cell_Culturing_Patent_FINAL_FOR_RELEASE.pdf
👍️ 2
FDApproved FDApproved 2 months ago
Pluri Selected as CDMO by Remedy Cell for Cell-Derived Cell-Free Drug Manufacturing

https://pluri-biotech.com/wp-content/uploads/2024/03/1710397832_1710357602_Pluri_CDMO_press_release_FINAL_FOR_RELEASE.pdf
👍️ 2
FDApproved FDApproved 2 months ago
Pluri Launches Advanced Global Cell Therapy Contract Development and Manufacturing Organization

https://pluri-biotech.com/wp-content/uploads/2024/01/1704687167_1704639961_CDMO_PR_FINAL_FOR_RELEASE.pdf
👍️ 2
FDApproved FDApproved 2 months ago
Pluri and Bar-Ilan University to Develop PLX Cells for the Treatment of Cocaine Addiction

https://pluri-biotech.com/wp-content/uploads/2023/12/1703156443_1703151841_Pluri_and_Bar_Ilan_University_FINAL.pdf
👍️ 2
FDApproved FDApproved 2 months ago
Step into the Future: Pluri Launches Sustainable Cell-Based Coffee as Countermeasure for Global Coffee Crisis

https://pluri-biotech.com/wp-content/uploads/2024/01/1705993672_Pluri_PR_Coffee_Launch_FINAL_FOR_RELEASE.pdf
👍️ 2
FDApproved FDApproved 2 months ago
Israeli startup Ever After Foods addresses ‘critical scaling challenge’ in cultivated meat: ‘We have a huge cost advantage’

https://agfundernews.com/ever-after-foods-addresses-critical-scaling-challenge-in-cultivated-meat#:~:text=He%20added%3A%20%E2%80%9CAn%20Ever%20After,have%20a%20huge%20cost%20advantage.%E2%80%9D
👍️ 2
FDApproved FDApproved 2 months ago
Pluri Is At 3 Conferences The Week Of April 8th !!!

https://pluri-biotech.com/media-events-events/
👍️ 2
FDApproved FDApproved 2 months ago
Pluri’s Business Verticals Gain Traction in Global Markets; Leadership to Participate and Present in Upcoming Conferences

https://pluri-biotech.com/wp-content/uploads/2024/03/1711621213_1711614542_Pluri_PR_re_Conferences_FINAL_FOR_RELEASE.pdf
👍️ 2

Your Recent History

Delayed Upgrade Clock